Follow‐up after chemoradiation for cervical cancer: Why?
Abstract
After treatment for cervical cancer, patients are followed to detect recurrent disease, to manage treatment‐related complications, and to address patient needs. FDG‐PET has been introduced as a potential tool in prognostication and selection of patients for “low‐risk” follow‐up.